Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Congress considering plan to allow 'biosimilars' to come to market
Marketwatch
Thursday, September 3, 2009 - 2:00pm
tags:
biogenerics, generics
Is Sepracor the Right Prescription for Dainippon Sumitomo?
WSJ Online
Thursday, September 3, 2009 - 10:53am
tags:
Sepracor, buyouts, Dainippon Sumitomo
Order In The Court! New Date for Biogen/Elan Hearing
InVivo
Thursday, September 3, 2009 - 10:50am
tags:
Biogen Idec, Elan
Merck launches eye pressure drug Saflutan in UK and Spain after regulatory approval
Yahoo/AP
Thursday, September 3, 2009 - 10:39am
tags:
Merck, UK, Spain, Saflutan
Valeant's Six New Value Aligned Pay Practices
Seeking Alpha
Thursday, September 3, 2009 - 10:37am
tags:
Valeant Pharmaceuticals
[video] Bio-Tech High Times
TheStreet.com
Thursday, September 3, 2009 - 10:36am
tags:
biotech, Spectrum Pharmaceuticals, Novavax, Biocryst
FDA Study Indicates Most Industry Postmarketing Studies Meet Timelines
Pharmaceutical Processing
Thursday, September 3, 2009 - 10:35am
tags:
FDA, postmarketing studies
Merck’s Latest Headache: First Fosamax Case Goes to Trial
WSJ Online
Thursday, September 3, 2009 - 10:32am
tags:
Merck, lawsuits, Fosamax, osteoporosis
Cancer drugs rising to top of sales pyramid
Fierce Pharma
Thursday, September 3, 2009 - 8:47am
tags:
cancer, drug sales
Bayer to Pay Up to $800 Million for Algeta’s New Drug
Bloomberg
Thursday, September 3, 2009 - 8:45am
tags:
Bayer, Algeta, Alpharadin, prostate cancer
Novartis Swine Flu Vaccine Shows Early Promise
Smart Money
Thursday, September 3, 2009 - 8:44am
tags:
Novartis, swine flu, vaccines, H1N1
Dainippon Sumitomo Pharma of Japan acquiring US drug maker Sepracor for $2.6 billion
Yahoo/AP
Thursday, September 3, 2009 - 8:15am
tags:
Dainippon Sumitomo, Sepracor, buyouts
Roche Drug Shrinks Tumors in Study
WSJ Online
Wednesday, September 2, 2009 - 6:54pm
tags:
Roche, skin cancer, Genentech
Abbott Labs to acquire Visiogen for $400 million
Marketwatch
Wednesday, September 2, 2009 - 4:43pm
tags:
Abbott Laboratories, Visiogen, vision care, M&A
Pfizer's Big News. Or Is It?
CNBC
Wednesday, September 2, 2009 - 4:43pm
tags:
Pfizer, Wyeth, Bextra, settlements
On the Radar: Five biotech companies to watch
Fierce Biotech
Wednesday, September 2, 2009 - 4:40pm
tags:
Rigel, Poniard, OncoGenex, MannKind, GTx, biotech
Good News for Novavax
Yahoo/Zacks.com
Wednesday, September 2, 2009 - 4:27pm
tags:
Novavax, vaccines, AstraZeneca, GSK, Flu
La Jolla Is Too Much of a Gamble Right Now
Seeking Alpha
Wednesday, September 2, 2009 - 10:41am
tags:
La Jolla Pharmaceutical, Cell Genesys
Short Interest in BioDelivery Sciences Is Good News
Seeking Alpha
Wednesday, September 2, 2009 - 10:41am
tags:
BioDelivery Sciences
Did Lexapro's success depend on doc payments?
Fierce Pharma
Wednesday, September 2, 2009 - 10:24am
tags:
Lexapro, physician payments, Forest Labs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.